- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Morning Market Movers: Polyrizon, Picard Medical, Crescent Biopharma, Hyster-Yale See Big Swings | 247 | AFX News | OTTAWA (dpa-AFX) - At 7:25 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| PICARD MEDICAL Aktie jetzt für 0€ handeln | |||||
| Mi | Picard Medical, Inc. and SynCardia Systems LLC CEO to Present at CSI Focus D-HF 2025 in Frankfurt, Germany | 2 | GlobeNewswire (USA) | ||
| Mi | Picard Medical, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 26.11. | Picard Medical, Inc.: Picard Medical to Present the Next Generation Fully Implantable SynCardia Total Artificial Heart at ISMCS 2025 | 1 | GlobeNewswire (USA) | ||
| 26.11. | Picard Medical, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 19.11. | Picard Medical, Inc.: SynCardia Completes First In Vivo Implantations of Next-Generation Emperor Total Artificial Heart | 7 | GlobeNewswire (USA) | ||
| 14.11. | Picard Medical Loss Narrows In Q3 | 6 | RTTNews | ||
| 14.11. | Picard Medical GAAP EPS of -$0.19, revenue of $1.19M | 2 | Seeking Alpha | ||
| 14.11. | Picard Medical, Inc.: Picard Reports Third Quarter 2025 Financial Results | 128 | GlobeNewswire (Europe) | - Completes IPO, Expands Patent Portfolio, and Strengthens Board Independence - TUCSON, Ariz., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) ("Picard" or the "Company")... ► Artikel lesen | |
| 14.11. | Picard Medical, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 14.11. | Picard Medical, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 12.11. | Picard Medical, Inc.: Picard to Attend the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum November 20, 2025, in New York City | 1 | GlobeNewswire (USA) | ||
| 24.10. | Picard Medical äußert sich zu Aktienvolatilität: Keine wesentlichen Änderungen bekannt | 9 | Investing.com Deutsch | ||
| 24.10. | Picard Medical says no material changes amid stock volatility | 2 | Investing.com | ||
| 24.10. | Picard Medical, Inc.: Picard Issues Statement on Intraday Stock Price | 250 | GlobeNewswire (Europe) | TUCSON, Ariz., Oct. 24, 2025 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) ("Picard" or the "Company"), parent company of SynCardia Systems LLC, maker of the world's first U.S. and... ► Artikel lesen | |
| 24.10. | From IPO Low To Market High To 65% Drop: Volatile Picard Medical Stock Ends Bull Run | 8 | Benzinga.com | ||
| 24.10. | Morning Market Movers: Picard Medical, Qualigen Therapeutics, Inhibrx Biosciences, MidWestOne Financial GroupSee Big Swings | 654 | AFX News | BEIJING (dpa-AFX) - At 7:45 a.m. ET on Friday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| 14.10. | Picard Medical, Inc. - 8-K, Current Report | 10 | SEC Filings | ||
| 22.09. | Picard Medical expands artificial heart IP with new U.S. patent | 4 | MassDevice | ||
| 22.09. | Picard Medical, Inc.: Picard Advances Patent Protection for Fully Implantable Artificial Heart Technology | 1 | GlobeNewswire (USA) |
1 2 3 Weiter >>
44 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PROCEPT BIOROBOTICS | 35,430 | +6,78 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 19,400 | +1,57 % | Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics | Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit... ► Artikel lesen | |
| PROGYNY | 24,150 | -1,63 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| GENEDX | 161,95 | +0,98 % | Cathie Wood's ARK sells Iridium, buys GeneDx and WeRide stock | ||
| BETA BIONICS | 30,000 | -1,32 % | Beta Bionics, Inc.: Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| CASTLE BIOSCIENCES | 39,620 | +0,53 % | Castle Biosciences, Inc.: New Data Confirms Performance of DecisionDx-Melanoma to Identify Patients with Less Than Five Percent Risk of Sentinel Lymph Node Positivity | FRIENDSWOOD, Texas, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced new data... ► Artikel lesen | |
| NUTEX HEALTH | 156,79 | 0,00 % | Nutex Health extends share repurchase plan | ||
| BRIGHTSPRING HEALTH SERVICES | 35,160 | +0,11 % | BMO Capital Maintains Bullish 12%+ BrightSpring EBITDA Growth Outlook on Drug Contract Wins, Generic Conversions | ||
| KESTRA MEDICAL TECHNOLOGIES | 24,500 | -5,11 % | Kestra Medical Technologies, Ltd.: Kestra Medical Technologies Reports Preliminary Second Quarter Fiscal 2026 Financial Results | KIRKLAND, Wash., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today reported preliminary financial... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 24,000 | -1,23 % | Privia Health Group, Inc.: Privia Health Reports Third Quarter 2025 Financial Results | Very Strong Third Quarter and Year-to-Date Performance Across the BusinessNet Income +94.1% and Adjusted EBITDA +61.6% compared to 3Q'24Implemented Providers +13.1% and Practice Collections +27.1%... ► Artikel lesen | |
| CERIBELL | 19,150 | +6,39 % | Ceribell Reports Third Quarter 2025 Financial Results | SUNNYVALE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 42,810 | +0,28 % | EQS-DD: Siemens Healthineers AG: Elisabeth Staudinger-Leibrecht, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
28.11.2025 / 17:23... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,520 | +1,27 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 9,135 | 0,00 % | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Announces Third Quarter Financial Results and Revised 2025 Outlook | Third Quarter Revenue was $621.9 million, a 22.2% increase over the prior year periodThird Quarter Net income was $14.1 million compared to Net loss of $42.8 million for the prior year periodAdjusted... ► Artikel lesen | |
| HEARTFLOW | 28,935 | +3,34 % | Heartflow, Inc.: Heartflow Announces FDA 510(k) Clearance and Launch of Next Generation Heartflow Plaque Analysis Platform | MOUNTAIN VIEW, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced it has received... ► Artikel lesen |
PICARD MEDICAL INC gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 3,710 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PICARD MEDICAL INC finden Sie auf Wallstreet Online.